Are bedtime nutritional strategies effective in preventing nocturnal hypoglycaemia in patients with type 1 diabetes?

Diabetes, Obesity and Metabolism

Volumn 16, Issue 7, 2014, Pages 577-587

  Desjardins, K ^a,b   Brazeau, A S ^a   Strychar, I ^b,c,d   Rabasa Lhoret, R ^a,b,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Montreal Diabetes Research Center MDRC   (Canada)

Author keywords

Hypoglycaemia; Medical nutrition therapy; Type 1 diabetes

Indexed keywords

ACARBOSE; ALANINE; CARBOHYDRATE; FAT; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN ZINC SUSPENSION; MILK FAT; STARCH; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LONG ACTING INSULIN;

ALCOHOL CONSUMPTION; AWARENESS; BEDTIME NUTRITIONAL TREATMENT; DIABETES MELLITUS; DIET THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; NOCTURNAL HYPOGLYCEMIA; PHYSICAL ACTIVITY; REVIEW; STANDING; ADMINISTRATION AND DOSAGE; BLOOD; CARBOHYDRATE DIET; CHEMICALLY INDUCED; COMPLICATION; EATING; FAST FOOD; HYPOGLYCEMIA; METABOLISM; TIME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; EATING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; SNACKS; STARCH; TIME FACTORS;

EID: 84903204189     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12232     Document Type: Review

References (52)

1. Canadian Diabetes Association. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian J Diabetes 2013; 37(Suppl. 1): S1-216.
2. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care 2013; 36(Suppl 1): S11-66.
3. The DCCT/EDIC Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-2569.
4. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90: 450-459.
5. Cryer PE. Hypoglycemia in diabetes: pathophysiology, prevalence, and prevention. 2nd edn. Alexandria, VA: American Diabetes Association, 2012; 236.
6. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010; 16: 244-248.
7. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med 2012; 29: 682-689.
8. Rankin D, Cooke DD, Heller S, Elliott J, Lawton J. Experiences of using blood glucose targets when following an intensive insulin regimen: a qualitative longitudinal investigation involving patients with type 1 diabetes. Diabet Med 2012; 29: 1079-1084.
9. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010; 33: 1004-1008.
10. Woodward A, Weston P, Casson IF, Gill GV. Nocturnal hypoglycaemia in type 1 diabetes - frequency and predictive factors. QJM 2009; 102: 603-607.
11. Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003; 52: 1195-1203.
12. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract 2005; 69: 14-21.
13. Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database Syst Rev 2008; 3: CD006297.
14. Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 2006; 23: 141-147.
15. Danne T, Kordonouri O, Holder M et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011; 13: 1129-1134.
16. Seaquist ER, Anderson J, Childs B et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 2013; 36: 1384-1395.
17. Whincup G, Milner RD. Prediction and management of nocturnal hypoglycaemia in diabetes. Arch Dis Child 1987; 62: 333-337.
18. Verny C, Remy C, Sachon C, Bosquet F, Casanova S, Grimaldi A. Nocturnal hypoglycemia in insulin-dependent diabetics. Presse Med 1995; 24: 1198-1200.
19. Schiffrin A, Suissa S. Predicting nocturnal hypoglycemia in patients with type I diabetes treated with continuous subcutaneous insulin infusion. Am J Med 1987; 82: 1127-1132.
20. Barton AL, Gilbertson HR, Donath SM, Cameron FJ. Is bedtime supper necessary for older children with diabetes using glargine insulin in multiple daily injection regimens? Diabet Med 2010; 27: 238-241.
21. Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen-storage disease. N Engl J Med 1984; 310: 171-175.
22. Ververs MT, Rouwe C, Smit GP. Complex carbohydrates in the prevention of nocturnal hypoglycaemia in diabetic children. Eur J Clin Nutr 1993; 47: 268-273.
23. Axelsen M, Wesslau C, Lonnroth P, Arvidsson Lenner R, Smith U. Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type 1 diabetes subjects. J Intern Med 1999; 245: 229-236.
24. Detlofson I, Kroon M, Aman J. Oral bedtime cornstarch supplementation reduces the risk for nocturnal hypoglycaemia in young children with type 1 diabetes. Acta Paediatr 1999; 88: 595-597.
25. Kaufman FR, Devgan S. Use of uncooked cornstarch to avert nocturnal hypoglycemia in children and adolescents with type I diabetes. J Diabetes Complications 1996; 10: 84-87.
26. Kaufman FR, Halvorson M, Kaufman ND. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995; 30: 205-209.
27. Kaufman FR, Halvorson M, Kaufman ND. Evaluation of a snack bar containing uncooked cornstarch in subjects with diabetes. Diabetes Res Clin Pract 1997; 35: 27-33.
28. Jenkins DJ, Wolever TM, Leeds AR et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978; 1: 1392-1394.
29. Wursch P, Pi-Sunyer FX. The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care 1997; 20: 1774-1780.
30. Rami B, Zidek T, Schober E. Influence of a beta-glucan-enriched bedtime snack on nocturnal blood glucose levels in diabetic children. J Pediatr Gastroenterol Nutr 2001; 32: 34-36.
31. Lodefalk M, Aman J, Bang P. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with Type 1 diabetes. Diabet Med 2008; 25: 1030-1035.
32. Wilson D, Chase HP, Kollman C et al. Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes. Pediatr Diabetes 2008; 9(4 Pt 1): 320-325.
33. Wiethop BV, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993; 16: 1124-1130.
34. Rossetti P, Porcellati F, Busciantella Ricci N et al. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes 2008; 57: 1905-1917.
35. Porcellati F, Pampanelli S, Rossetti P et al. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. Diabetologia 2007; 50: 422-430.
36. Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997; 20: 1231-1236.
37. Kalergis M, Schiffrin A, Gougeon R, Jones PJ, Yale JF. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial. Diabetes Care 2003; 26: 9-15.
38. Raju B, Arbelaez AM, Breckenridge SM, Cryer PE. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab 2006; 91: 2087-2092.
39. Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson JL. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care 1999; 22: 667-673.
40. McCulloch DK, Kurtz AB, Tattersall RB. A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care 1983; 6: 483-487.
41. Simpson RW, McDonald J, Wahlqvist ML, Atley L, Outch K. Macronutrients have different metabolic effects in nondiabetics and diabetics. Am J Clin Nutr 1985; 42: 449-453.
42. Wolever TM, Mullan YM. Sugars and fat have different effects on postprandial glucose responses in normal and type 1 diabetic subjects. Nutr Metab Cardiovasc Dis 2011; 21: 719-725.
43. MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987; 10: 584-588.
44. Yardley JE, Kenny GP, Perkins BA et al. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care 2012; 35: 669-675.
45. Cheyne EH, Sherwin RS, Lunt MJ, Cavan DA, Thomas PW, Kerr D. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes. Diabet Med 2004; 21: 230-237.
46. Richardson T, Weiss M, Thomas P, Kerr D. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 2005; 28: 1801-1802.
47. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. The relationship between nonroutine use of insulin, food, and exercise and the occurrence of hypoglycemia in adults with IDDM and varying degrees of hypoglycemic awareness and metabolic control. Diabetes Educ 1997; 23: 55-58.
48. Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005; 28: 186-212.
49. The Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003; 5: 781-9.
50. Francescato MP, Geat M, Stel G, Cauci S. Accuracy of a portable glucose meter and of a Continuous Glucose Monitoring device used at home by patients with type 1 diabetes. Clin Chim Acta 2012; 413(1-2): 312-318.
51. Oliver NS, Toumazou C, Cass AE, Johnston DG. Glucose sensors: a review of current and emerging technology. Diabet Med 2009; 26: 197-210.
52. Melki V, Ayon F, Fernandez M, Hanaire-Broutin H. Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. Diabetes Metab 2006; 32: 123-129.